Medix Biochemica Revenue and Competitors

Stoneham, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Medix Biochemica's estimated annual revenue is currently $36.4M per year.(i)
  • Medix Biochemica's estimated revenue per employee is $155,000

Employee Data

  • Medix Biochemica has 235 Employees.(i)
  • Medix Biochemica grew their employee count by 4% last year.

Medix Biochemica's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Operations & Supply ChainReveal Email/Phone
4
VP Immunodiagnostic ReagentsReveal Email/Phone
5
VP IVD Business UnitReveal Email/Phone
6
Director OperationsReveal Email/Phone
7
Director Quality Assurance and Regulatory AffairsReveal Email/Phone
8
Medix Weston Site Lead: Director, Product Management – Biospecimens, Base Matrices, BiologicalsReveal Email/Phone
9
Chief People OfficerReveal Email/Phone
10
Director Product ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Medix Biochemica?

Medix Biochemica develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry as well as POC tests for human health care. MedixMAB product line includes monoclonal antibodies and antigens e.g. in cardiovascular, diabetes, fertility, infectious diseases, metabolism, serology, thyroid and tumor fields. In addition, Medix Biochemica offers flexible and customized services for diagnostic industry: recombinant antibody development, contract manufacturing of antibodies, antibody conjugation and coating of microplates. Actim rapid tests are easy to use bedside tests e.g. for pregnancy monitoring (detection of membrane rupture and screening for risk of preterm delivery), immunological FOB testing, screening of acute Pancreatitis and acute disease detecting (CRP, Influenza A&B, RSV, Noro). Diagnostics, Monoclonal antibodies, Antigens, Rapid tests

keywords:N/A

N/A

Total Funding

235

Number of Employees

$36.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medix Biochemica News

2022-04-20 - Preterm Birth And PROM Testing Market Size, Scope And ...

... LLC., Hologic CooperSurgical Abbott Laboratories, Medix Biochemica, Sera prognostics, Clinical Innovations, LLC., Biosynex,...

2022-04-17 - Preterm Birth And PROM Testing Market Size And Forecast ...

Qiagen Sciences, LLC., Hologic CooperSurgical Abbott Laboratories, Medix Biochemica, Sera prognostics, Clinical Innovations, LLC., Biosynex,...

2022-04-17 - Global Premature Rupture of Membranes (PROM) Testing ...

... Membranes (PROM) Testing Market 2022 Industry Growth and Product Scope 2028 | Top Players as Abbott, Qiagen, Medix Biochemica, Hologic.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M16470%N/A